Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study
The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 m...
Gespeichert in:
Veröffentlicht in: | Journal of cardiovascular pharmacology 1997-05, Vol.29 (5), p.612-617 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 617 |
---|---|
container_issue | 5 |
container_start_page | 612 |
container_title | Journal of cardiovascular pharmacology |
container_volume | 29 |
creator | Vaïsse, B Herpin, D Asmar, R Battistella, P Zannad, F Boutelant, S Lyon, A Conte, D Denis, J Honore, Ph Contard, S Prost, P-L Mallion, J M Poggi, L |
description | The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 min). Patients were subdivided into two groupsthe "High" group, with 24-h mean values of systolic BP (SBP) >137 or diastolic BP (DBP) >87 mm Hg, and the "Low" group, with SBP ≤ 137 and DBP ≤ 87 mm Hg. All patients received, in a random and double-blind design, either bisoprolol (10 mg q.d.) or lisinopril (20 mg q.d.) for 8 weeks. At the end of this active treatment period office and ambulatory BP measurements were performed. Casual measurements revealed similar BP decreases in all subgroups receiving bisoprolol and lisinopril; BP monitoring showed that the antihypertensive effect depended on the baseline mean 24-h value; −15/−12 mm Hg for bisoprolol and −18/−13 mm Hg for lisinopril in the High group; −7/−6 mm Hg for bisoprolol and −6/−6 mm Hg for lisinopril in the Low group. This study shows that the antihypertensive effect depended on initial ambulatory BP values, with a lower BP decrease in the Low group. Assessment of the antihypertensive effect on ambulatory BP is useful in clinical trials. |
doi_str_mv | 10.1097/00005344-199705000-00008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79103266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79103266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4348-6c2f6de3fbc6b4232b5f066802b6ab182220587a28e029413bd61d0d9165fb9a3</originalsourceid><addsrcrecordid>eNp1kcuOEzEQRS0EGoaBT0DyArFr8Kvd3eySYXhIQSAB65bdXSYGxw4uN6N8AP-Nh4Ts8Kbke0_ZpbqEUM5ecDZ0L1k9rVSq4cPQsbbemjupv0cueStlo5iQ98kl45o1Qin9kDxC_M4YV22nL8jFILgUTF6S3ytEQNxBLDQ5uorFbw97yAUi-l9Ab5yDqVB7oOuQ0kw_5UovGeiHFH1J2cdvr-hqvw9-MsWniLQkuvaY9jmFFKiJM9149LEKPlAfqaGv02IDNOvgq_m5LPPhMXngTEB4cqpX5Oubmy_X75rNx7fvr1ebZlJS9Y2ehNMzSGcnbZWQwraOad0zYbWxvBdCsLbvjOiBiUFxaWfNZzYPXLfODkZekefHd-t0PxfAMu48ThCCiZAWHLuBMym0rmB_BKecEDO4sY6_M_kwcjbeJTD-S2A8J_BX6mvr09Mfi93BfG48rbz6z06-wckEl02cPJ4x0emeD6Ji6ojdplAg44-w3EIet2BC2Y7_y1_-Ad9VnpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79103266</pqid></control><display><type>article</type><title>Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Vaïsse, B ; Herpin, D ; Asmar, R ; Battistella, P ; Zannad, F ; Boutelant, S ; Lyon, A ; Conte, D ; Denis, J ; Honore, Ph ; Contard, S ; Prost, P-L ; Mallion, J M ; Poggi, L</creator><creatorcontrib>Vaïsse, B ; Herpin, D ; Asmar, R ; Battistella, P ; Zannad, F ; Boutelant, S ; Lyon, A ; Conte, D ; Denis, J ; Honore, Ph ; Contard, S ; Prost, P-L ; Mallion, J M ; Poggi, L</creatorcontrib><description>The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 min). Patients were subdivided into two groupsthe "High" group, with 24-h mean values of systolic BP (SBP) >137 or diastolic BP (DBP) >87 mm Hg, and the "Low" group, with SBP ≤ 137 and DBP ≤ 87 mm Hg. All patients received, in a random and double-blind design, either bisoprolol (10 mg q.d.) or lisinopril (20 mg q.d.) for 8 weeks. At the end of this active treatment period office and ambulatory BP measurements were performed. Casual measurements revealed similar BP decreases in all subgroups receiving bisoprolol and lisinopril; BP monitoring showed that the antihypertensive effect depended on the baseline mean 24-h value; −15/−12 mm Hg for bisoprolol and −18/−13 mm Hg for lisinopril in the High group; −7/−6 mm Hg for bisoprolol and −6/−6 mm Hg for lisinopril in the Low group. This study shows that the antihypertensive effect depended on initial ambulatory BP values, with a lower BP decrease in the Low group. Assessment of the antihypertensive effect on ambulatory BP is useful in clinical trials.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-199705000-00008</identifier><identifier>PMID: 9213203</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive agents ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Bisoprolol - therapeutic use ; Blood Pressure Monitoring, Ambulatory ; Cardiovascular system ; Double-Blind Method ; Female ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Lisinopril - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments</subject><ispartof>Journal of cardiovascular pharmacology, 1997-05, Vol.29 (5), p.612-617</ispartof><rights>Lippincott-Raven Publishers</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4348-6c2f6de3fbc6b4232b5f066802b6ab182220587a28e029413bd61d0d9165fb9a3</citedby><cites>FETCH-LOGICAL-c4348-6c2f6de3fbc6b4232b5f066802b6ab182220587a28e029413bd61d0d9165fb9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-199705000-00008$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005344-199705000-00008$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2768192$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9213203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaïsse, B</creatorcontrib><creatorcontrib>Herpin, D</creatorcontrib><creatorcontrib>Asmar, R</creatorcontrib><creatorcontrib>Battistella, P</creatorcontrib><creatorcontrib>Zannad, F</creatorcontrib><creatorcontrib>Boutelant, S</creatorcontrib><creatorcontrib>Lyon, A</creatorcontrib><creatorcontrib>Conte, D</creatorcontrib><creatorcontrib>Denis, J</creatorcontrib><creatorcontrib>Honore, Ph</creatorcontrib><creatorcontrib>Contard, S</creatorcontrib><creatorcontrib>Prost, P-L</creatorcontrib><creatorcontrib>Mallion, J M</creatorcontrib><creatorcontrib>Poggi, L</creatorcontrib><title>Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 min). Patients were subdivided into two groupsthe "High" group, with 24-h mean values of systolic BP (SBP) >137 or diastolic BP (DBP) >87 mm Hg, and the "Low" group, with SBP ≤ 137 and DBP ≤ 87 mm Hg. All patients received, in a random and double-blind design, either bisoprolol (10 mg q.d.) or lisinopril (20 mg q.d.) for 8 weeks. At the end of this active treatment period office and ambulatory BP measurements were performed. Casual measurements revealed similar BP decreases in all subgroups receiving bisoprolol and lisinopril; BP monitoring showed that the antihypertensive effect depended on the baseline mean 24-h value; −15/−12 mm Hg for bisoprolol and −18/−13 mm Hg for lisinopril in the High group; −7/−6 mm Hg for bisoprolol and −6/−6 mm Hg for lisinopril in the Low group. This study shows that the antihypertensive effect depended on initial ambulatory BP values, with a lower BP decrease in the Low group. Assessment of the antihypertensive effect on ambulatory BP is useful in clinical trials.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bisoprolol - therapeutic use</subject><subject>Blood Pressure Monitoring, Ambulatory</subject><subject>Cardiovascular system</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Lisinopril - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcuOEzEQRS0EGoaBT0DyArFr8Kvd3eySYXhIQSAB65bdXSYGxw4uN6N8AP-Nh4Ts8Kbke0_ZpbqEUM5ecDZ0L1k9rVSq4cPQsbbemjupv0cueStlo5iQ98kl45o1Qin9kDxC_M4YV22nL8jFILgUTF6S3ytEQNxBLDQ5uorFbw97yAUi-l9Ab5yDqVB7oOuQ0kw_5UovGeiHFH1J2cdvr-hqvw9-MsWniLQkuvaY9jmFFKiJM9149LEKPlAfqaGv02IDNOvgq_m5LPPhMXngTEB4cqpX5Oubmy_X75rNx7fvr1ebZlJS9Y2ehNMzSGcnbZWQwraOad0zYbWxvBdCsLbvjOiBiUFxaWfNZzYPXLfODkZekefHd-t0PxfAMu48ThCCiZAWHLuBMym0rmB_BKecEDO4sY6_M_kwcjbeJTD-S2A8J_BX6mvr09Mfi93BfG48rbz6z06-wckEl02cPJ4x0emeD6Ji6ojdplAg44-w3EIet2BC2Y7_y1_-Ad9VnpA</recordid><startdate>199705</startdate><enddate>199705</enddate><creator>Vaïsse, B</creator><creator>Herpin, D</creator><creator>Asmar, R</creator><creator>Battistella, P</creator><creator>Zannad, F</creator><creator>Boutelant, S</creator><creator>Lyon, A</creator><creator>Conte, D</creator><creator>Denis, J</creator><creator>Honore, Ph</creator><creator>Contard, S</creator><creator>Prost, P-L</creator><creator>Mallion, J M</creator><creator>Poggi, L</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199705</creationdate><title>Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study</title><author>Vaïsse, B ; Herpin, D ; Asmar, R ; Battistella, P ; Zannad, F ; Boutelant, S ; Lyon, A ; Conte, D ; Denis, J ; Honore, Ph ; Contard, S ; Prost, P-L ; Mallion, J M ; Poggi, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4348-6c2f6de3fbc6b4232b5f066802b6ab182220587a28e029413bd61d0d9165fb9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bisoprolol - therapeutic use</topic><topic>Blood Pressure Monitoring, Ambulatory</topic><topic>Cardiovascular system</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Lisinopril - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaïsse, B</creatorcontrib><creatorcontrib>Herpin, D</creatorcontrib><creatorcontrib>Asmar, R</creatorcontrib><creatorcontrib>Battistella, P</creatorcontrib><creatorcontrib>Zannad, F</creatorcontrib><creatorcontrib>Boutelant, S</creatorcontrib><creatorcontrib>Lyon, A</creatorcontrib><creatorcontrib>Conte, D</creatorcontrib><creatorcontrib>Denis, J</creatorcontrib><creatorcontrib>Honore, Ph</creatorcontrib><creatorcontrib>Contard, S</creatorcontrib><creatorcontrib>Prost, P-L</creatorcontrib><creatorcontrib>Mallion, J M</creatorcontrib><creatorcontrib>Poggi, L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaïsse, B</au><au>Herpin, D</au><au>Asmar, R</au><au>Battistella, P</au><au>Zannad, F</au><au>Boutelant, S</au><au>Lyon, A</au><au>Conte, D</au><au>Denis, J</au><au>Honore, Ph</au><au>Contard, S</au><au>Prost, P-L</au><au>Mallion, J M</au><au>Poggi, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1997-05</date><risdate>1997</risdate><volume>29</volume><issue>5</issue><spage>612</spage><epage>617</epage><pages>612-617</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 min). Patients were subdivided into two groupsthe "High" group, with 24-h mean values of systolic BP (SBP) >137 or diastolic BP (DBP) >87 mm Hg, and the "Low" group, with SBP ≤ 137 and DBP ≤ 87 mm Hg. All patients received, in a random and double-blind design, either bisoprolol (10 mg q.d.) or lisinopril (20 mg q.d.) for 8 weeks. At the end of this active treatment period office and ambulatory BP measurements were performed. Casual measurements revealed similar BP decreases in all subgroups receiving bisoprolol and lisinopril; BP monitoring showed that the antihypertensive effect depended on the baseline mean 24-h value; −15/−12 mm Hg for bisoprolol and −18/−13 mm Hg for lisinopril in the High group; −7/−6 mm Hg for bisoprolol and −6/−6 mm Hg for lisinopril in the Low group. This study shows that the antihypertensive effect depended on initial ambulatory BP values, with a lower BP decrease in the Low group. Assessment of the antihypertensive effect on ambulatory BP is useful in clinical trials.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>9213203</pmid><doi>10.1097/00005344-199705000-00008</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0160-2446 |
ispartof | Journal of cardiovascular pharmacology, 1997-05, Vol.29 (5), p.612-617 |
issn | 0160-2446 1533-4023 |
language | eng |
recordid | cdi_proquest_miscellaneous_79103266 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Adrenergic beta-Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive agents Antihypertensive Agents - therapeutic use Biological and medical sciences Bisoprolol - therapeutic use Blood Pressure Monitoring, Ambulatory Cardiovascular system Double-Blind Method Female Humans Hypertension - drug therapy Hypertension - physiopathology Lisinopril - therapeutic use Male Medical sciences Middle Aged Pharmacology. Drug treatments |
title | Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A21%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20Antihypertensive%20Effect%20by%20Blood%20Pressure%20Monitoring:%20Applications%20to%20Bisoprolol%20and%20Lisinopril%20in%20a%20Double-Blind%20Study&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Va%C3%AFsse,%20B&rft.date=1997-05&rft.volume=29&rft.issue=5&rft.spage=612&rft.epage=617&rft.pages=612-617&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-199705000-00008&rft_dat=%3Cproquest_cross%3E79103266%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79103266&rft_id=info:pmid/9213203&rfr_iscdi=true |